公司資料
Cerus Corporation 股價、新聞與催化劑
- 股票代碼:
- CERS
- 交易所:
- NASDAQ
- 產業:
- Biopharma
- 所在地:
- United States
股票表現
2.66 USD (+5.14%)
收盤價
最後更新: 2026年9月17日
541M USD
市值
股價為何變動
截至 2026年9月17日，CERS 上漲 5.14%，收於 $2.66。目前新聞監測窗口內未發現新的同公司新聞。
公司概覽
業務概覽
Cerus is a blood-safety company focused on pathogen-reduction technology for platelets, plasma, and red blood cells. Its business is centered on making transfusions safer through a proprietary platform.
所在地與產業分類
Headquartered in the United States and listed on NASDAQ, Cerus sits in blood products and healthcare infrastructure.
商業模式特徵
The company depends on blood-center adoption, product utilization, and the expansion of pathogen-reduction systems.
生技產業定位
Cerus is a niche transfusion-safety company that trades on adoption and operational execution rather than drug catalysts.
未來催化劑
- Cerus’s next three months are about INTERCEPT Blood System adoption in platelets, plasma, and whole blood. The market will watch whether the company can keep converting blood-safety workflow into steady recurring demand.
近期新聞
新聞標題由機器翻譯，詳情為英文原文。
相似股票
商業成熟度、治療領域或催化劑模式相近的同業公司。